Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.

Juurlink BH.

Mult Scler Int. 2013;2013:598093. doi: 10.1155/2013/598093. Epub 2013 Apr 4.

2.

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report.

Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R.

BMC Med. 2011 Mar 7;9:22. doi: 10.1186/1741-7015-9-22.

3.

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.

van Zuuren EJ, Fedorowicz Z, Pucci E, Jagannath VA, Robak EW.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009903. doi: 10.1002/14651858.CD009903.pub2. Review.

PMID:
23235683
4.

Vascular aspects of multiple sclerosis.

D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J.

Lancet Neurol. 2011 Jul;10(7):657-66. doi: 10.1016/S1474-4422(11)70105-3. Review.

PMID:
21683931
5.

Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity.

Garaci FG, Marziali S, Meschini A, Fornari M, Rossi S, Melis M, Fabiano S, Stefanini M, Simonetti G, Centonze D, Floris R.

Radiology. 2012 Oct;265(1):233-9. Epub 2012 Aug 21.

PMID:
22915599
6.

Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.

Diaconu CI, Conway D, Fox RJ, Rae-Grant A.

Curr Treat Options Cardiovasc Med. 2012 Apr;14(2):203-14. doi: 10.1007/s11936-012-0168-7.

PMID:
22311713
7.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.

Ingrisch M, Sourbron S, Herberich S, Schneider MJ, Kümpfel T, Hohlfeld R, Reiser MF, Ertl-Wagner B.

Invest Radiol. 2017 Mar;52(3):135-141. doi: 10.1097/RLI.0000000000000320.

PMID:
27548346
8.

A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F.

J Vasc Surg. 2009 Dec;50(6):1348-58.e1-3. doi: 10.1016/j.jvs.2009.07.096. Erratum in: J Vasc Surg. 2010 Apr;51(4):1079.

9.

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.

Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M.

J Neurol Sci. 2009 Jul 15;282(1-2):28-33. doi: 10.1016/j.jns.2008.12.036. Epub 2009 Jan 31.

10.

CCSVI is associated with multiple sclerosis.

Morovic S, Zamboni P.

Neurol Res. 2012 Oct;34(8):770-9. doi: 10.1179/1743132812Y.0000000035. Review.

PMID:
22971467
11.

Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.

Paling D, Tozer D, Wheeler-Kingshott C, Kapoor R, Miller DH, Golay X.

J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):785-92. doi: 10.1136/jnnp-2012-302541. Epub 2012 May 23.

PMID:
22626944
12.

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.

van Zuuren EJ, Fedorowicz Z, Pucci E, Jagannath V, Robak EW.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):405-10. doi: 10.1136/jnnp-2013-305481. Epub 2013 Jun 18. Review.

PMID:
23781006
13.

Reduced perfusion in white matter lesions in multiple sclerosis.

Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK.

Eur J Radiol. 2015 Dec;84(12):2605-12. doi: 10.1016/j.ejrad.2015.09.007. Epub 2015 Sep 10.

PMID:
26391230
14.

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

De Keyser J, Steen C, Mostert JP, Koch MW.

J Cereb Blood Flow Metab. 2008 Oct;28(10):1645-51. doi: 10.1038/jcbfm.2008.72. Epub 2008 Jul 2. Review.

PMID:
18594554
15.

Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.

Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.

Neuroimage. 2006 Jan 15;29(2):637-42. Epub 2005 Aug 29.

PMID:
16126413
16.

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H.

J Neuropathol Exp Neurol. 2003 Jan;62(1):25-33.

PMID:
12528815
17.

Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.

Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI.

Radiology. 2004 Jun;231(3):645-52.

PMID:
15163806
18.

Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI.

AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1539-47.

19.

Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.

Melief J, Schuurman KG, van de Garde MD, Smolders J, van Eijk M, Hamann J, Huitinga I.

Glia. 2013 Nov;61(11):1848-61. doi: 10.1002/glia.22562. Epub 2013 Sep 6.

PMID:
24014207
20.

Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.

Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE 3rd, Dwyer MG.

Neurol Res. 2008 Oct;30(8):816-26. doi: 10.1179/174313208X341003.

PMID:
18826808

Supplemental Content

Support Center